Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus

Circulation. 2014 Jun 17;129(24):2567-73. doi: 10.1161/CIRCULATIONAHA.113.006634.

Authors

Allison B Goldfine¹, Eng-Joo Phua², Martin J Abrahamson²

Affiliations

¹ From the Joslin Diabetes Center and Harvard Medical School, Boston, MA. allison.goldfine@joslin.harvard.edu.
² From the Joslin Diabetes Center and Harvard Medical School, Boston, MA.

No abstract available

Publication types

Case Reports
Research Support, N.I.H., Extramural
Review

MeSH terms

Aged
Blood Glucose / metabolism*
Coronary Artery Disease* / complications
Coronary Artery Disease* / drug therapy
Coronary Artery Disease* / metabolism
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / metabolism
Humans
Hypoglycemic Agents / therapeutic use*
Male
Myocardial Infarction / complications
Myocardial Infarction / drug therapy
Myocardial Infarction / metabolism
Prediabetic State* / complications
Prediabetic State* / drug therapy
Prediabetic State* / metabolism

Substances

Blood Glucose
Hypoglycemic Agents

Grants and funding